Riboxin
200 mg № 10, № 50
Group of action
Active ingredient
Dosage form
Film-coated tablets
ATC code
C01EB
RX/OTC
RX
Marketing authorisation no.
UA/6774/01/01
General properties
Pharmacotherapeutic group
Cardiac drugs. Inosine.
Indications
- Comprehensive treatment of coronary heart disease (post-myocardial infarction, angina),
- heart rhythm disorders,
- cardiac glycosides intoxication drugs,
- treatment of cardiomyopathies of various origins,
- myocardiodystrophy (against the background of heavy physical exertion, infectious and endocrine genesis),
- myocarditis;
- liver disease (hepatitis, cirrhosis, fatty liver);
- uroporphyria.
Contraindications
Hypersensitivity to the active substance or to other components of the drug. Gout, hyperuricemia. Restrictions on the reception of Riboxinum is renal failure.
Pharmaceutical characteristics
Basic physical and chemical properties
Round-shaped tablets, coated, from light yellow to yellow color, the upper and lower surfaces are convex. At the break when viewed under a microscope can see a core surrounded by one continuous layer.
Shelf life
3 years.
Storage conditions
Keep in original package at temperature not exceeding 25 oС.
Keep out of reach of children.
Manufacturer
PJSC "Technolog".
Location
8, Stara Prorizna st., Uman 20300 Cherkasy region, Ukraine.
